Anuh Pharma Ltd (506260)

₹240.95▲2.57%

Get free price alerts. Set up your Free investment account to get Live Prices. >

Overview

Fundamentals

Q3 '23 Results

Technicals

News and Events

Anuh Pharma Ltd share Performance

₹239.1
₹253
₹240.95
0.77%
Low
Day's Volatility:5.77%
High
5.00%
₹86.05
₹265
₹240.95
64.29%
Low
52 Weeks Volatility:74.27%
High
9.98%

Returns %
1 Month Return	-2.21 %
3 Month Return	44.62 %
1 Year Return	176 %

Market Stats
Previous Close	₹247.30
Open	₹247.30
Volume	84.61K
Upper Circuit	-
Lower Circuit	-
Market Cap	₹1,239.27Cr

Company Information

Anuh Pharma Ltd is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) in India and part of the SK group. Since its incorporation in 1960, its been well-positioned in servicing their existing and potential markets at Tarapur in Maharashtra, in addition to being a recognized export house with markets in Mexico, Brazil, Iran, Bangladesh, Colombia, Germany, Africa, Singapore, and more. With the recent investments in modern facilities and addition of new plants, the installed capacity of the company has increased dramatically – from 400,000kg to 600,000kg for antibiotics and up to 150MT per annum. In 2010, their efforts were rewarded with approvals from the European Directorate for the Quality of Medicines and Healthcare (EDQM) for three products – Erythromycin E.P., Pyrazinamide, and Clobetasol Propionate – opening up opportunities for the company to sell their products in European countries for local consumption.

Share Price: ₹240.95 per share as on 03 May, 2024 04:01 PM
Market Capitalisation: ₹1,239.27Cr as of today
Listing date: 01 Jan, 0001
Chairperson Name: Jasvantlal Shah

Organisation	Anuh Pharma Ltd
Headquarters
Industry	Pharmaceuticals
E-voting on shares	Click here to vote

Key events for Anuh Pharma Ltd

Anuh Pharma Ltd Shares Gain 2% During Trading Session - 20 Feb, 2024
Anuh Pharma Ltd shares gained around 2% during the trading session, hitting a high of Rs. 235. The company's revenue increased by 15% from Rs. 150 crores to Rs. 172 crores in the December quarter, while net profits magnified by 36%. Anuh Pharma has delivered a multibagger of 165% to its investors in one year.

Fundamentals of Anuh Pharma Ltd

Insights on Anuh Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, Anuh Pharma stock has moved up by 44.6%
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, Anuh Pharma has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.00% to 0.03% in Mar 2024 quarter
NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.4% return, outperforming this stock by 56.4%
NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 69.94% to 69.92% in Mar 2024 quarter
NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 30.06% to 29.95% in Mar 2024 quarter